These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15675270)

  • 1. [Effectiveness of selected methods of the short-term intensive insulin therapy in patients with poorly controlled type 2 diabetes mellitus].
    Ruxer J; Mozdzan M; Czupryniak L; Saryusz-Wolska M; Loba J
    Pol Arch Med Wewn; 2004 Aug; 112(2):945-52. PubMed ID: 15675270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients].
    Mozdzan M; Mozdzan M; Loba J; Markuszewski L; Ruxer J
    Wiad Lek; 2006; 59(3-4):203-7. PubMed ID: 16813265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
    Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
    J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
    Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
    Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
    Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
    Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial.
    Metzger M; Castañeda J; Reznik Y; Giorgino F; Conget I; Aronson R; de Portu S; Runzis S; Lee SW; Cohen O
    Diabetes Obes Metab; 2017 Oct; 19(10):1490-1494. PubMed ID: 28374511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients.
    Boullu-Sanchis S; Ortega F; Chabrier G; Busch MS; Uhl C; Pinget M; Jeandidier N
    Diabetes Metab; 2006 Sep; 32(4):350-7. PubMed ID: 16977263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
    Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H
    Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight-Based Insulin During and After Intravenous Insulin Infusion Reduces Rates of Rebound Hyperglycemia When Transitioning to Subcutaneous Insulin in the Medical Intensive Care Unit.
    Zhou K; Buehler LA; Zaw T; Bena J; Lansang MC
    Endocr Pract; 2022 Feb; 28(2):173-178. PubMed ID: 34687910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
    Pettus J; Edelman SV
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes.
    Lin CH; Hsieh SH; Sun JH; Tsai JS; Huang YY
    Sci Rep; 2015 Nov; 5():16968. PubMed ID: 26607841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.